About Bone Medical Limited (ASX BNE)

Bone Medical Limited is engaged in the development of improved therapeutics to prevent and/or treat bone and joint diseases and conditions, especially osteoporosis, osteoarthritis and arthritis. As of June 30, 2010, Bone Medical Limited is managing three clinical projects and one pre-clinical project. The major focus has been on Capsitonin and CaPTHymone (oral parathyroid hormone) for the treatment of osteroporosis. It also includes the development of Capsitonin (oral Calcitonin) for the treatment of Osteoarthritis. Bone Limited, wholly owned subsidiary of Bone Medical Limited, has licence agreements for the technologies of Axcess, Mozaic, Vaxcine, and Lexicon from the licensors Axcess Limited, Mozaic Discovery Limited, Vaxcine Limited and Lexcicon Limited.

Bone Medical Limited Chart and Share Price



Buy, sell or hold Bone Medical? Be the first to comment!